Additionally, we revealed that the fractions of CD8+ T cells, Tfh cells, activated memory CD4+ T cells and M1 macrophages were associated with a favorable response, PFS and OS after ICI therapy in melanoma and urothelial cancer. This evidence concerns the gene CD8A and melanoma.